(Q35164724)

6 August 2017

1 reference

title

ACE inhibitors and AT-1-receptor antagonists COOPERATE in non-diabetic renal disease (English)

1 reference

6 August 2017

Sheila A Doggrell

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Expert Opinion on Pharmacotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

4

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

1185-1188

1 reference

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.7.1185

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.7.1185

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.7.1185

Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.7.1185

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.7.1185

10.1517/14656566.4.7.1185

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference